ash highlights in cll and lymphoma by dr andrew zelenetz
Published 8 years ago • 163 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
4:10
john gribben’s ash 2019 cll and lymphoma highlights
-
1:35
highlights of ash in cll
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks
-
2:09
ash highlights in cll: moving towards fixed-duration treatment, the role of mrd & alpine results
-
2:57
lymphoma highlights from ash 2021
-
1:47
ash cll highlights: ibrutinib-venetoclax combination & undetectable mrd in ighv-mutated patients
-
2:08
ash highlights: results of the triangle study in mcl
-
1:53
cll highlights from ash 2023: the flair study
-
2:49
ash clinical news: june 2022 from the desk of...
-
4:51
the current frontline treatment strategy in multiple myeloma
-
1:01:22
chronic lymphocytic leukemia at ash21: what's new?
-
1:00
ash 2022 lba: results from final analysis of alpine - zanubrutinib vs ibrutinib for r/r cll/sll
-
2:01
cll and lymphoma updates from ash: 2023 best of hematology
-
1:00
phase ib trial of r-chop plus iberdomide or cc-99282 in aggressive b-cell lymphoma
-
0:56
cmml highlights from ash 2022
-
0:41
ash 2021 highlights in cml
-
2:14
highlights in lymphoma at ash 2020
-
3:35
trial of ibrutinib with bendamustine and rituximab in cll: results and study design
-
1:33
lymphoma: highlights at ash 2020
-
3:08
aml highlights from ash 2017
-
2:07
side-effect of idelalisib and its use in chronic lymphocytic leukemia
-
3:29
cll case studies presented at bsh/ish 2016